News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Judith D. Bebchuk

Articles by Judith D. Bebchuk

TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study

ByPooja Advani, MBBS, MD,Sofia Braga,Adam M. Brufsky, MD, PhD,Karthik V. Giridhar,Erica L. Mayer, MD, MPH,Kelly E. McCann,Ruth M. O’Regan,Cristina Saura,Seth A. Wander,Georg F. Bischof,Beth H. Lowenthal,Judith D. Bebchuk,Lisa D. Eli,Brian G. Barnett,Joyce A. O’Shaughnessy,Tufia C. Haddad

April 11th 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Novel Blood-Based Prostate Cancer Test for Elevated PSA Levels

FDA Grants Fast Track Designation to Novel FLT3/CD3 Bispecific in R/R AML

FDA Gives Traditional Approval to Pirtobrutinib in CLL/SLL

Zanidatamab Shows Meaningful Benefit in HER2+ Biliary Tract Cancer

JANX007 Displays Encouraging Safety/Efficacy in Metastatic CRPC

© 2025 MJH Life Sciences^®

All rights reserved.